Pinned Tweet
FEBS Press febs.onlinelibrary.wiley.com… I am beyond thrilled to share our latest publication showing a new combinatorial therapy for the treatment of very aggressive tumors in the liver. Read it and share it!!
#PhD #PhDlife #Science #MolecularOncology #Targetedtherapies #published
increible el servicio de @Renfe ... los billetes anulados por el apagón solo se pueden cambiar/anular por teléfono el mismo día que salía el tren... pero ayer llamabas y estaba colapsado... hoy me lo cogen y me dicen que me vaya a la estación como UNICA SOLUCION @Inforenfe
2
243
que hago? me cojo el dia libre para ir hasta Sants a hacer cola y que cambien el billete? es una verguenza... ayer llames mas de 10 veces y ni siquiera me dejaban quedarme esperando a que me atendieran, me colgaban diciendo que habian muchas llamadas y hoy esto... @Renfe
66
Attending the #Envisionsummit2024 from @_SOLTI . Exciting for the first talk, #DavidCescon talks about new drugs (combinations).
#CancerResearch #BreastCancer #Science
2
81
Antonio Mulero retweeted
Thrilled to see our ExIGS tool featured! A true testament to the power of collaboration. Huge congrats to the team for their hard work! 🧬@ajaylabade31 @z_chiang @CarolineComenho nature.com/articles/d41586-0…
Antonio Mulero retweeted
🎥 Yesterday at #ESMO24, @G_Villacampa presented: "Association of RAD51 and efficacy outcomes in patients with HER2-negative #breastcancer and homologous recombination deficiency: post-hoc analysis of the GeparOla trial"
Watch the video for more details! 👇 – at Hospitalet de Llobregat, Spain
Haciendo historia
Enhorabuena @carlosalcaraz por esta inmensa victoria!!!! Grande!!!! Muy contento por tus éxitos !!! 🇪🇸 #Vamos
1
114
Antonio Mulero retweeted
¿Sabías que...
...un medicamento que destruye las células malignas refuerza el papel de la inmunoterapia en uno de los tumores de pulmón más agresivos? #FRIDAYnews📰 de SOLTI de esta semana, te recomendamos un artículo sobre el tema, que nos ha parecido interesante:
📰¿Dónde? @elpais_salud
✍️¿Quién? @CinzasNoPeto
📍¿Qué? "Nuevos fármacos contra el cáncer de mama más agresivo"
🎯¿Cómo? descúbrelo tú mism@ 👇
Antonio Mulero retweeted
We are closing the circle, we got @matteolambe to stop by our #Cyclibtool booth in #ESMOBREAST24 😂 Thank you Matteo!
@Rodrosb @hmasanas
Antonio Mulero retweeted
Dr. @TomasPascualMD presenting SOLTI trials such as CORALLEEN in his lecture "Unlocking the potential of biomarker-based trial designs in advancing new therapeutics" in #ESMOBREAST24
#beSOLTI
Antonio Mulero retweeted
❄️❗️ Hallan un 'corazón de hielo' que alerta de la posibilidad de que la Antártida desaparezca de manera repentina ver.abc.es/6zh_4
Antonio Mulero retweeted
Closing off one pathway in one place is often not enough to block a tumor. A treatment discovered by @anthonymuler (@hetAVL @uniutrecht) involving two drugs is currently being tested in the clinic.
Antonio will defend his thesis on October 19 ➡️ bit.ly/3RY1v3y
Antonio Mulero retweeted
Replying to @qbas81 @parents4futureG
Thank you for making the effort to follow the facts and for your action. I hadn’t heard of this group, thanks for making me aware. I’m not a parent but will pass it along to friends with children.
Antonio Mulero retweeted
🧵12/n (ENDS)
I will be sailing north now for another few weeks, before disembarking and taking a much needed rest.
From there, it’s back to the ocean conservation fight.
Recharged and ready to win.
Bring it on 💪🏻
🐋
P.S. I’m looking for my next opportunity 👋🏻
Outstanding talk of @valientelab today at the @NKI_nl! Very impressive data about brain metastasis and how different we should tackle them and treat them!! Very proud of the science done in Spain. #Science #Spain #PhD
Pero si me vais a retrasar un tren a las 7AM avisarme y duermo más! #carnaval #antonioenfurecido #carnival
2
148
It is now official!! There you go! #molecularoncology #Science #PhD #pfdlife #targetedtherapies #EACR
Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma
🔓buff.ly/3lkAvgd
#CRCSM #TargetedTherapy
#HCC #OncoAlert
1
15
1,440













